- Home
- RNXT vs ASRV Comparison
RNXT vs ASRV Comparison
Compare RNXT & ASRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNXT | ASRV |
|---|---|---|
| Founded | 2012 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.4M | 78.4M |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | RNXT | ASRV |
|---|---|---|
| Price | $1.17 | $4.78 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.25 | N/A |
| AVG Volume (30 Days) | ★ 385.0K | 20.0K |
| Earning Date | 11-05-2026 | 10-20-2026 |
| Dividend Yield | N/A | ★ 2.53% |
| EPS Growth | 20.00 | ★ 61.90 |
| EPS | N/A | ★ 0.27 |
| Revenue | $1,123,000.00 | ★ $14,634,000.00 |
| Revenue This Year | $243.48 | N/A |
| Revenue Next Year | $196.42 | N/A |
| P/E Ratio | ★ N/A | $17.44 |
| Revenue Growth | ★ 2511.63 | N/A |
| 52 Week Low | $0.70 | $2.96 |
| 52 Week High | $2.59 | $5.38 |
Technical Indicators
Market Signals| Indicator | RNXT | ASRV |
|---|---|---|
| Relative Strength Index (RSI) | 41.10 | 57.60 |
| Support Level | $0.83 | $3.62 |
| Resistance Level | $1.30 | $4.98 |
| Average True Range (ATR) | 0.16 | 0.28 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 43.28 | 91.78 |
Price Performance
Historical ComparisonAbout RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical needs with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed for targeted therapeutic delivery across the arterial wall near the tumor site (known as intra-arterial, or IA delivery) to bathe the target tumor, while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.